OphtiMed Rx
Novel Molecular Treatment for Dry Age-related Macular Degeneration
Active
Seed
Startup
Afula
Founded 2021-11
OphtiMed Rx is developing a novel molecular therapy for dry age-related macular degeneration (AMD), a common eye disease leading to blindness. The company’s treatment protects retinal cells from senescence (cellular aging) and can halt the progression of dry AMD. OphtiMed Rx’s therapy is designed to prevent the loss of vision and independence caused by dry…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$1.3M
Employees4
Founded2021-11
HQAfula
Patents1
Confidence88
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareLaboratories